SUNNYVALE, Calif., Sept. 15, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that Kevin Waters, formerly Senior Vice President, Finance, has been promoted to Chief Financial Officer of the Company effective as of today. He succeeds Gregory E. Lichtwardt who retired as Executive Vice President, Operations, and Chief Financial Officer of the Company effective as of September 14, 2015. Mr. Lichtwardt will continue in a consulting role with the Company for an interim period.
"When Greg agreed to join Accuray a few years back, he did so with the mutual understanding that he would retire from the Company within a few years time," said Josh Levine, President & CEO. "It was with that timetable in mind that Kevin Waters joined us. Kevin's promotion to the role of Chief Financial Officer is a testament to the high quality finance team that Greg has built at Accuray over the past two years. Kevin has been working closely with Greg and is fully prepared to assume the CFO responsibilities as well as execute a smooth transition with Greg. I deeply appreciate the many contributions Greg has made to our company during his tenure and look forward to working with Kevin as we continue to move Accuray forward."
Mr. Waters joined Accuray as its Senior Vice President, Finance, in October, 2013. Prior to joining Accuray, Mr. Waters was employed by Conceptus Inc., a global leader in the development and commercialization of innovative device-based solutions in permanent birth control, as its Corporate Controller from October, 2006 until January, 2008, and most recently as its Vice President, Finance, from January, 2008, until October, 2013. Mr. Waters began his career at PricewaterhouseCoopers, LLP.
Ad Statistics
Times Displayed: 138204
Times Visited: 7980 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Commenting on his appointment, Mr. Waters said, "I am excited to lead our talented team of finance professionals. Accuray has made great financial progress during Greg Lichtwardt's tenure and I hope to build on that success going forward. Having worked with Greg for the past nine years, we share many of the same fundamental business principles as well as strategies on how to build businesses that enhance shareholder value."
"I'm proud of what we've achieved over the last two years and believe that the Company is well-positioned for the future," said Mr. Lichtwardt.
About Accuray
Accuray Incorporated (Nasdaq: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com.
